Jack Nathan Medical (TSE:JNH) has released an update.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Jack Nathan Health reported a 16% year-to-date revenue growth in its Q3 fiscal 2025 results, driven primarily by its expanding operations in Mexico. The company has completed the sale of its Canadian operations and is focusing on growing its Mexican clinics and exploring opportunities in the MedSpa sector.
For further insights into TSE:JNH stock, check out TipRanks’ Stock Analysis page.